Picture of Oncolys Biopharma logo

4588 — Oncolys Biopharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Table: Oncolys Biopharma - Q1 parent results

May 2 (Reuters)-  
             Oncolys Biopharma Inc.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended        Year to    
                Mar 31, 2017        Mar 31, 2016       Dec 31, 2017   
                   LATEST             YEAR-AGO            LATEST      
                   RESULTS             RESULTS           FORECAST     
  Sales            15 mln              29 mln            200 mln      
                 (-48.0 pct)                           (+112.4 pct)   
  Operating     loss 235 mln        loss 182 mln        loss 1.40     
  Recurring     loss 241 mln        loss 185 mln        loss 1.40     
  Net           loss 242 mln        loss 186 mln        loss 1.40     
  EPS          loss 25.91 yen      loss 20.28 yen    loss 152.08 yen  
  Ann Div                                NIL               NIL        
  -Q2 div                                NIL               NIL        
  -Q4 div                                NIL               NIL        
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Oncolys Biopharma

See all news